Tevogen Bio Holdings Inc.
TVGN
Get informed when a big investor buys or sells
+ FollowMarket Cap$32.52M
Close$
$-0.77
109.8% downside
Current Fair Value
109.8% downsideOvervalued by 109.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $32.52 Million |
|---|---|
| Enterprise Value | $34.48 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-8.08 |
| Beta | 0.19 |
| Outstanding Shares | 3,829,365 |
Return
| Return on Equity | 243.15% |
|---|---|
| Return on Assets | -457.14% |
| Return on Invested Capital | 1499.44% |
Valuation & Multiples
| P/E Ratio | -1.34 |
|---|---|
| PEG | -28.58 |
| Price to Sales | - |
| Price to Book Ratio | -2.6 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.62 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | -0.34 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-2.53
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 13, 2026
EPS Estimate
$-2.56
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 2.82%▼ 1.07% |
|---|---|
| Total Invested | $611,913▼ 0.36% |
| Investors Holding | 31▲ 2.00% |
ESG Score
No data